CEO of vaccine maker Emergent sold $10 million in stock before company ruined Johnson & Johnson dosesThe chief of Emergent BioSolutions made sales of stock options weeks before the company’s share price tumbled.CEO of vaccine maker Emergent sold $10 million in stock before company ruined Johnson & Johnson doses